184 related articles for article (PubMed ID: 31121145)
1. The continuing burden of Rh disease 50 years after the introduction of anti-Rh(D) immunoglobin prophylaxis: call to action.
Visser GHA; Di Renzo GC; Spitalnik SL;
Am J Obstet Gynecol; 2019 Sep; 221(3):227.e1-227.e4. PubMed ID: 31121145
[TBL] [Abstract][Full Text] [Related]
2. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
Kumpel BM
Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
[No Abstract] [Full Text] [Related]
3. Cost-effectiveness of the management of rh-negative pregnant women.
Duplantie J; Gonzales OM; Bois A; Nshimyumukiza L; Gekas J; Bujold E; Morin V; Vallée M; Giguère Y; Gagné C; Rousseau F; Reinharz D
J Obstet Gynaecol Can; 2013 Aug; 35(8):730-740. PubMed ID: 24007709
[TBL] [Abstract][Full Text] [Related]
4. Rh(O)D immune globulin products for prevention of alloimmunization during pregnancy.
Aitken SL; Tichy EM
Am J Health Syst Pharm; 2015 Feb; 72(4):267-76. PubMed ID: 25631833
[TBL] [Abstract][Full Text] [Related]
5. Fifty years of RhD immunoglobulin (anti-D) therapy in Australia: celebrating a public health success story.
Thyer J; Wong J; Thomson A; Bell B; Hyland C; Challis D
Med J Aust; 2018 Oct; 209(8):336-339. PubMed ID: 30309307
[No Abstract] [Full Text] [Related]
6. Recommendations for the use of anti-D immunoglobulin for Rh prophylaxis. British Blood Transfusion Society and the Royal College of Obstetricians and Gynaecologists.
Lee D; Contreras M; Robson SC; Rodeck CH; Whittle MJ
Transfus Med; 1999 Mar; 9(1):93-7. PubMed ID: 10216910
[No Abstract] [Full Text] [Related]
7. Rh negative status and isoimmunization update: a case-based approach to care.
Harrod KS; Hanson L; VandeVusse L; Heywood P
J Perinat Neonatal Nurs; 2003; 17(3):166-78; quiz 179-80. PubMed ID: 12959478
[TBL] [Abstract][Full Text] [Related]
8. Prevention of Rh alloimmunization.
Fung Kee Fung K; Eason E; Crane J; Armson A; De La Ronde S; Farine D; Keenan-Lindsay L; Leduc L; Reid GJ; Aerde JV; Wilson RD; Davies G; Désilets VA; Summers A; Wyatt P; Young DC;
J Obstet Gynaecol Can; 2003 Sep; 25(9):765-73. PubMed ID: 12970812
[TBL] [Abstract][Full Text] [Related]
9. [Hemolytic disease of the newborn has not vanished from Finland--routine protection of RhD negative mothers during pregnancy is justifiable].
Sainio S; Kuosmanen M
Duodecim; 2012; 128(2):151-7. PubMed ID: 22372070
[TBL] [Abstract][Full Text] [Related]
10. Hemolytic disease of the fetus and newborn due to Rh(D) incompatibility: A preventable disease that still produces significant morbidity and mortality in children.
Pegoraro V; Urbinati D; Visser GHA; Di Renzo GC; Zipursky A; Stotler BA; Spitalnik SL
PLoS One; 2020; 15(7):e0235807. PubMed ID: 32687543
[TBL] [Abstract][Full Text] [Related]
11. Is the management of Rh-Rh incompatibility with noninvasive fetal Rh genotyping for targeted prophylaxis cost-effective in the Turkish population?
Demirel E; Kelekçi S; Ekmekci E; Şengül M; İri R; Atasever M
Turk J Med Sci; 2018 Feb; 48(1):1-4. PubMed ID: 29479934
[TBL] [Abstract][Full Text] [Related]
12. [Prenatal immunoglobulin prevention in Rh(D)-negative nonsensitized pregnant women].
Katsulov A
Akush Ginekol (Sofiia); 1997; 36(2):1-2. PubMed ID: 9471891
[No Abstract] [Full Text] [Related]
13. [Antenatal anti-Rh(D) antigen prophylaxis].
Katsulov A;
Akush Ginekol (Sofiia); 2001; 40 Suppl 5():3-7. PubMed ID: 11785354
[No Abstract] [Full Text] [Related]
14. Rh-immunoglobulin: Rh prophylaxis.
Bowman J
Best Pract Res Clin Haematol; 2006; 19(1):27-34. PubMed ID: 16377539
[No Abstract] [Full Text] [Related]
15. Guideline No. 448: Prevention of Rh D Alloimmunization.
Fung-Kee-Fung K; Wong K; Walsh J; Hamel C; Clarke G
J Obstet Gynaecol Can; 2024 Apr; 46(4):102449. PubMed ID: 38553007
[TBL] [Abstract][Full Text] [Related]
16. [Antenatal anti-Rh(D) antigen prophylaxis of Rh/-/- pregnancy in women on first consultation at the St. Sofia Obstetrics-Gynecology Hospital -- Sofia].
Katsulov A; Iankov M; Zlateva K; Blagova A; Gogova K; Savova S
Akush Ginekol (Sofiia); 2001; 40 Suppl 5():7-8. PubMed ID: 11785356
[No Abstract] [Full Text] [Related]
17. The history of rhesus prophylaxis with anti-D.
Wegmann A; Glück R
Eur J Pediatr; 1996 Oct; 155(10):835-8. PubMed ID: 8891551
[No Abstract] [Full Text] [Related]
18. Incidence of maternal sensitisation to Rh(D) in Christchurch, New Zealand and reasons for prophylaxis failures.
Badami KG; Parker J; Kenny A; Warrington S
N Z Med J; 2014 Jan; 127(1388):40-6. PubMed ID: 24481385
[TBL] [Abstract][Full Text] [Related]
19. Do Rh-negative women with first trimester spontaneous abortions need Rh immune globulin?
Hannafin B; Lovecchio F; Blackburn P
Am J Emerg Med; 2006 Jul; 24(4):487-9. PubMed ID: 16787810
[TBL] [Abstract][Full Text] [Related]
20. [The expediency of producing antirhesus-Rh0(D) immunoglobulin and its use for preventing hemolytic disease of the newborn (for discussion)].
Mikhaĭlova AA; Klimova NIa
Gematol Transfuziol; 1992; 37(7-8):39-40. PubMed ID: 1342987
[No Abstract] [Full Text] [Related]
[Next] [New Search]
